Tag: BriaCell Therapeutics Corp


BriaCell Therapeutics Corp (NASDAQ: BCTX) Jumps 6.5% After Announcing Expansion of Its Breast Cancer Platform Tech

BriaCell Therapeutics Corp (NASDAQ: BCTX) jumped 6.51% after the company announced its targeted oncology therapy advancement into other novel immunotherapy cell lines: Bria-Mel for melanoma Bria-lung for lung cancer, and Bria-Pros from Prostate cancer.  BriaCell developing personalized cancer immunotherapies  The company’s immunotherapy treatment seemed to be effective in breast cancer […]


BriaCell Therapeutics Corp. (Nasdaq: BCTX) Soars on Account of Positive OS Data From Breast Cancer Treatment

BriaCell Therapeutics Corp. (NASDAQ: BCTX), the clinical-stage biotechnology company, recently reported the overall survival benefit of its ongoing advanced breast cancer study. The company released overall survival (OS) data of women under treatment of Bria-IMT™, the company’s lead candidate for monotherapy in breast cancer. Bria-IMT™ is used alongside checkpoint inhibitors […]